Recruiting Lymphoma Studies in Des Moines
AZD0486 as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of AZD0486 monotherapy in adult participants with relapsed/refractory B-cell non-Hodgkin lympho...
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
The study will measure the safety, tolerability, and efficacy with acalabrutinib in combination with rituximab in treatment-naïve elderly and/or frail patients with diffuse large B-cell lymphoma (DLBC...
About Lymphoma Clinical Trials in Des Moines
Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.
There are currently 2 lymphoma clinical trials recruiting participants in Des Moines, IOWA. These studies are seeking a combined 320 participants. Research is being sponsored by AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lymphoma Clinical Trials in Des Moines — FAQ
Are there lymphoma clinical trials in Des Moines?
Yes, there are 2 lymphoma clinical trials currently recruiting in Des Moines, IOWA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Des Moines?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Des Moines research site will contact you about next steps.
Are clinical trials in Des Moines free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Des Moines studies also compensate for your time and travel.
What lymphoma treatments are being tested?
The 2 active trials in Des Moines are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov